From Liston Street Pulse:
Shares of Osiris Therapeutics Inc. (OSIR) have skyrocketed in trading today after the biotechnology company announced its study results. The company said that the clinical trial comparing the safety and effectiveness of Grafix to standard care in patients with chronic diabetic foot ulcers met the pre-specified stopping rules. The news sent OSIR shares to a […]
The post Osiris Therapeutics Shares Skyrocket appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015